Save Product
Product Details
Source
Chimeric Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) is recombinantly expressed in HEK293. It consists of rabbit variable regions genetically fused to rabbit IgG constant domains.
Antibody Type
Recombinant Monoclonal
Clone
M5D04
Isotype
Rabbit IgG, Kappa
Host Species
Rabbit
Immunogen
DM-1-BSA
Specificity
Specifically recognizes the target DM-1 & DM-4.
Application
ApplicationRecommended Use / PerformanceELISA0.2-2 μg/mLPurification
Protein A purified.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Lyophilized
Formulation
Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Reconstitution
Please refer to the Certificate of Analysis (CoA) for specific instructions.
Shipping
Lyophilized product is shipped at ambient temperature.
Storage
For long term storage, the product should be stored in a lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA
Immobilized Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) (Cat. No. DM1-MY2358) at 5 μg/mL, add DM1 Antibody Human IgG in the 100% Human Serum and then add Biotinylated Human Her2, His,Avitag, premium grade (Cat. No. HE2-H82E2) at 0.5 μg/mL. Detection was performed using HRP-conjugated Streptavidin (Acro, Cat. No. STN-NH913) (QC tested).
Protocol
Immobilized Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) (Cat. No. DM1-MY2358) at 1 μg/mL (100 μL/well) can bind DM1 Antibody Human IgG with a linear range of 0.004-0.125 μg/mL (Routinely tested).
Protocol
Serial dilutions of DM1 were added into Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) (Cat. No. DM1-MY2358): DM1 Antibody Human IgG binding reactions. The half maximal inhibitory concentration (IC50) is 3.149 μg/mL (Routinely tested).
Protocol
Cross Verification
ELISA binding of Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) (Cat. No. DM1-MY2358) with DM1 Antibody Human IgG, Trastuzumab Deruxtecan, Sacituzumab Govitecan, Trastuzumab MMAE and IgG1-MMAF conjugated antibody respectively.
The coating antibody was Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) (Cat. No. DM1-MY2358), used at 1 μg/mL concentration. The primary antibody were different payload conjugated antibodies, including DM1 Antibody Human IgG, Trastuzumab Deruxtecan, Sacituzumab Govitecan, Trastuzumab MMAE and IgG1-MMAF conjugated antibodies used at 0.5 μg/mL concentration. The secondary antibody was HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb (Acro, Cat. No. IGG-LY69) used at 1:10000 concentration.
Monoclonal Anti-DM-1 Antibody, Rabbit IgG (M5D04) (Cat. No. DM1-MY2358) is specific to DM1 Antibody Human IgG, and has no cross-reactivity with Trastuzumab Deruxtecan, Sacituzumab Govitecan, Trastuzumab MMAE and IgG1-MMAF (Routinely tested).
Customer Reviews Writing Reviews
Preguntas Frecuentes
- product
Can lyophilized proteins remain stable during room-temperature shipping or temporary room-temperature exposure?
In general, lyophilized proteins remain stable during room-temperature shipping or temporary exposure to room-temperature conditions.
Many ACROBiosystems recombinant proteins are supplied in lyophilized (freeze-dried) form. The lyophilization process effectively removes moisture from the product, helping reduce degradation-related reactions and improve protein stability during transportation and storage.
To evaluate the stability of lyophilized proteins under normal temperature conditions, ACROBiosystems conducted a stability study on 11 representative lyophilized protein products at 37°C. The study demonstrated that these proteins maintained good quality stability after storage at 37°C for approximately 20 days. Based on these validation results, temporary room-temperature exposure during shipping or handling is generally not expected to have a significant impact on product quality or downstream application performance.
To ensure optimal long-term stability, products should be stored according to the storage conditions specified in the product Certificate of Analysis (COA) upon receipt.
Supporting Document
Contact Us
Drug Candidate Licensing
